Search for: "Lupin Limited"
Results 41 - 60
of 80
Sort by Relevance
|
Sort by Date
31 May 2011, 8:38 pm
– response to OPPI vice chairman’s interview with the Financial Express (Spicy IP) Japan: IP High Court guidance on availability of patent term extension for new forms of previously approved medicine (The SPC Blog) Japan – IP High Court offers guidance on patent term extension for combination of known drugs (The SPC Blog) Switzerland – The Swiss Federal Supreme Court approves new dosage regime as patentable subject matter in Swiss Type Claims under the EPC 1973 – Merck… [read post]
20 Jan 2011, 1:03 pm
., Lupin Limited, and Lupin Pharmaceuticals, Inc. [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
10 Nov 2010, 1:11 am
Highlights this week included: US government intervenes in patentability of genes – AMP v USPTO (Patent Baristas) (Holman’s Biotech IP Blog) (Intellectual Property Law Blog) (Inovia) (BlawgIT) (IP Osgoode) Temodar (Temozolomide) – US: CAFC limits prosecution laches defense: Cancer Research Technology v Barr Laboratories (Inventive Step) (IPBiz) (Patently-O) (SmartBrief) Italian antitrust authority opens preliminary investigation into whether Pfizer subsidiary artificially… [read post]
1 Nov 2010, 11:41 am
Lupin, Ltd. et al., 2-10-cv-00080 (NJD October 27, 2010, Order) (Hochberg, J.). [read post]
14 Oct 2010, 10:50 pm
Warner Chilcott has announced to settle pending patent lawsuits against Lupin Limited over Warner's oral contraceptive drugs Loestrin 24 FE and Femcon FE. [read post]
24 Sep 2010, 1:15 pm
Lupin Ltd., 499 F.3d 1293 (Fed. [read post]
2 Sep 2010, 10:51 am
Lupin, Ltd., 499 F.3d 1293 (Fed. [read post]
18 Aug 2010, 12:19 am
Apotex Pty Ltd; CSL Limited v. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]
14 Jul 2010, 6:47 pm
(EPLAW) EU Court of Justice limits scope of patent protection available to gene sequences: Monsanto v. [read post]
16 May 2010, 9:59 pm
One of the limitations on patents entitled... [read post]
13 May 2010, 4:58 pm
Lupin; Photocure v. [read post]
29 Mar 2010, 10:02 am
I think those posters are Greek for, “If you can’t maintain it, sell it” … or something With Greece (in March) and Dubai (in February), sovereign bankruptcy has moved from an abstract to a reality being denied, as seen chronicled in Dubai’s latest modified limited hangout, Always with the fine print: Am I allowed to gloat? [read post]
24 Mar 2010, 4:45 am
Lupin Ltd. et al. [read post]
22 Mar 2010, 6:21 am
I felt like Harry, Ron, or Hermione being revived by Lupin's chocolates. [read post]
17 Feb 2010, 8:00 am
Lupin Ltd. and Lupin Pharmaceuticals Inc. [read post]
10 Feb 2010, 4:47 pm
Lupin Ltd. et al. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
20 Jan 2010, 12:34 pm
First case was filed on 6th day of the year 2010 by Teva Women’s Health (Duramed) against Pune-based generic manufacturer Lupin Limited (Teva Women’s Health, Inc. v. [read post]
